Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Everolimus for established cardiac allograft vasculopathy after heart transplantation
2005-002220-34Phase 3Completed
- Sponsor
- Fundación Investigación y Desarrollo Área Cardiovascular
- Start
- Sep 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of everolimus in coronary vasculopathy (2 arms), sponsored by Fundación Investigación y Desarrollo Área Cardiovascular. Primary endpoint: Incidence of major adverse clinical events. Started Sep 2005; status: completed.
02
Drugs
everolimus
03
Conditions
coronary vasculopathy
Beyond the preview
Go deeper on 2005-002220-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-002220-34.